Tumor Markers In Gynecological Practice

Life Sciences & Biotechnology Update, Feb, 2001

This translation from Nigeria (University College Hospital) addresses tumor markers in gynecological practice. Gynecological cancers are fairly common in developing countries and represent about 26% of all cancers. Application of cervical cytology screening, nationally, has made cervical cancer one of the most preventable malignant diseases, thus eliminating the challenges of advanced cancer management. Tumor markers play a most crucial role in this respect.

(Order this LIFE SCIENCES & BIOTECHNOLOGY UPDATE reviewed report from InfoTeam Inc., P.O. Box 15640, Plantation, FL 33318-5640; Phone (954) 473-9560, Fax (954) 473-0544: Report No. L20010228; 1999, 6 pp. Price: $89.00, prepaid.)

COPYRIGHT 2001 Merton Allen Associates
COPYRIGHT 2001 Gale Group

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here

Content provided in partnership with Thompson Gale